COMPARISON BETWEEN HALOPERIDOL AND RISPERIDONE IN DEVELOPMENT OF METABOLIC SYNDROME IN INDIAN PATIENTS

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 6

Abstract

Introduction: It is well known that anti-psychotics are associated with many side effects. One of the significant adverse drug reactions among these is weight gain and development of metabolic syndrome. In this study, we compared the most widely used drugs Haloperidol and Risperidone for development of metabolic syndrome in treatment naïve patients with one episode of Schizophrenia. Methods: We took a total of 45 patients who were diagnosed to have Schizophrenia. All these patients never took any anti-psychotic in their live, nor did they take any other medicine for CNS/Psychiatry disorder. Among these 45 patients, 16 patients were put on Haloperidol and 29 patients were prescribed Risperidone. Patients with endocrine disturbances, any systemic disorders, etc. were removed from the study. The baseline characteristics of all the patients were properly studied and recorded. The characteristics were recorded again after 6 months and comparison was done by statistical methods. Results: PANSS score showed a decrease in both groups, systolic blood pressure showed an increase with Haloperidol and an initial decrease with risperidone while diastolic blood pressure increased with haloperidol. Weight gain, increase in waist circumference, rise in triglyceride levels and fall in HDL cholesterol were equally observed in both groups. Increase in plasma glucose was seen more with risperidone (93.1%). 18.86% (n = 10) developed metabolic syndrome at the end of 6months with no difference in emergence between both groups. Conclusion: Risperidone is considered equivalent to Haloperidol in efficacy but it is associated with increase in the components of metabolic syndrome.

Authors and Affiliations

Chaitanya Patel

Keywords

Related Articles

PHARMACEUTICAL STUDIES ON THE EFFECT OF DIFFERENT POLOXAMERS ON THE DISOLUTION RATE OF BSC CLASS II ANTIGOUT MODEL DRUG (FEBUXOSTAT)

The aim of the present work was to increase the dissolution rate of febuxostat (FXT) (Xanthine oxidase enzyme inhibitor), a practically water-insoluble drug using solid dispersion with hydrophilic polymers. Two commercia...

ASSESSMENT OF BREAST FEEDING AMONG CHILDREN WITH ASTHMATIC IN MEDICAL CITY / BAGHDAD

Background: Breast feeding is the ideal method for infant's nutrition, is considered as the first immunization dose which can protect the infant from several diseases. It is reducing the incidence of allergies such as as...

ASSESSMENT OF THE NURSING STUDENTS' KNOWLEDGE TOWARD THE ELDERLY HIP FRACTURES IN BAGHDAD CITY

Background: One of the most serious fall injuries is a broken hip. It is hard to recover from a hip fracture and afterward many people are not able to live on their own. Aims: To assess the nursing students' knowledge to...

AMAZING ROLE OF SELENIUM IN BIOLOGICAL SYSTEM

Selenium is essential trace element, sulphur analogue with high chemical activity, component of some selenoproteins and enzymes: glutathione peroxidase and other peroxidases, blood and tissue proteins. As to their biolog...

BLOOD BIOCHEMICAL AND HAEMATOLOGICAL ALTERATIONS IN SCHISTOSOMA MANSONI INFECTED PATIENTS IN IJORA – BADIA NIGERIA

Schistosomiasis is an infection of significant health concern. The aim of this study was to assess the alterations of some blood biochemical and haematological parameters in Schistosoma mansoni infected patients. Blood s...

Download PDF file
  • EP ID EP670953
  • DOI -
  • Views 171
  • Downloads 0

How To Cite

Chaitanya Patel (2019). COMPARISON BETWEEN HALOPERIDOL AND RISPERIDONE IN DEVELOPMENT OF METABOLIC SYNDROME IN INDIAN PATIENTS. European Journal of Biomedical and Pharmaceutical Sciences, 6(6), 121-123. https://europub.co.uk/articles/-A-670953